Opioids Should Not Be Used in Migraine

被引:56
|
作者
Tepper, Stewart J. [1 ]
机构
[1] Cleveland Clin, Headache Ctr, Cleveland, OH 44195 USA
来源
HEADACHE | 2012年 / 52卷
关键词
opioid; migraine; narcotic; acute treatment; chronic migraine; nociception; PREVENTION AMPP; HEADACHE; PREVALENCE; MEDICATIONS; ANALGESICS; DEPENDENCE; DIAGNOSIS; EM;
D O I
10.1111/j.1526-4610.2012.02140.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Opioids should not be used for the treatment of migraine. This brief review explores why not. Alternative acute and preventive agents should always be explored. Opioids do not work well clinically in migraine. No randomized controlled study shows pain-free results with opioids in the treatment of migraine. Saper and colleagues' 5-year study showed minimal effectiveness, with many contract violations, interfering with the therapeutic alliance. The physiologic consequences of opioid use are adverse, occur quickly, and can be permanent. Decreased gray matter, release of calcitonin gene-related peptide, dynorphin, and pro-inflammatory peptides, and activation of excitatory glutamate receptors are all associated with opioid exposure. Opioids are pro-nociceptive, prevent reversal of migraine central sensitization, and interfere with triptan effectiveness. Opioids precipitate bad clinical outcomes, especially transformation to daily headache. They cause disease progression, comorbidity, and excessive health care consumption. Use of opioids in migraine is pennywise and pound foolish.
引用
收藏
页码:30 / 34
页数:5
相关论文
共 50 条
  • [21] Should Physicians Recommend Replacing Opioids With Cannabis?
    Humphreys, Keith
    Saitz, Richard
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 321 (07): : 639 - 640
  • [22] What efficacy measures are clinically relevant and should be used in Cochrane Reviews of acute migraine trials? A viewpoint
    Tfelt-Hansen, Peer
    CEPHALALGIA, 2015, 35 (05) : 457 - 459
  • [23] Dyspnea Can Be, and Should Be, Effectively Palliated with Opioids
    Bascom, Paul B.
    JOURNAL OF PALLIATIVE MEDICINE, 2013, 16 (05) : 465 - 465
  • [24] Migraine Outcome Should Not Be Used to Determine Diagnosis, Severity, and Therapy: Moving Towards a Multiparametric Definition of Chronicity
    Alberto Raggi
    Matilde Leonardi
    Simona Sacco
    Paolo Martelletti
    Pain and Therapy, 2022, 11 : 331 - 339
  • [25] Migraine Outcome Should Not Be Used to Determine Diagnosis, Severity, and Therapy: Moving Towards a Multiparametric Definition of Chronicity
    Raggi, Alberto
    Leonardi, Matilde
    Sacco, Simona
    Martelletti, Paolo
    PAIN AND THERAPY, 2022, 11 (02) : 331 - 339
  • [26] The use of opioids for refractory chronic migraine: Efficacy and predictors of success
    Robbins, L.
    HEADACHE, 2008, 48 : S65 - S66
  • [27] General Neurologists' prescription practices for migraine attacks with emphasis on opioids
    Ernesto, Bancalari B.
    Astrid, Wicht S.
    CEPHALALGIA, 2022, 42 (14) : NP9 - NP10
  • [28] Acute Efficacy of Telcagapant in Migraine Patients with Prior Use of Opioids
    Ho, A. P.
    Kost, J. T.
    Dahlof, C. G. H.
    Silberstein, S. D.
    Froman, S.
    Leibensperger, H.
    Lines, C.
    Ho, T. W.
    HEADACHE, 2010, 50 : S31 - S32
  • [29] Should be used to cameras
    Patterson, D
    AVIATION WEEK & SPACE TECHNOLOGY, 2000, 152 (05): : 9 - 9
  • [30] What efficacy measures are clinically relevant and should be used in Cochrane reviews of acute migraine trials? An alternative viewpoint
    Steiner, T. J.
    CEPHALALGIA, 2015, 35 (05) : 460 - 462